Estimating the risk of solid organ malignancy in patients undergoing routine computed tomography scans after endovascular aneurysm repair  by Motaganahalli, Raghu et al.
From the Midwestern Vascular Surgical Society
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Objective: Computed tomography (CT) scans are routinely used for graft surveillance in patients who have had
endovascular repair (EVAR) of an abdominal aortic aneurysm. There is a growing concern for cancers associated with
inadvertent use of CT scans.We report the estimated risk of radiation associated solid organmalignancy caused by routine
surveillance CT after EVAR using the Biological Effects of Ionizing Radiation (BEIR VII) model created by U.S.
National Institute of Science and National Research Council.
Methods: Our study estimated the excess relative risk (ERR) of a patient acquiring a solid organ malignancy secondary to
radiation exposure from postoperative EVAR surveillance CT imaging. The radiation dose was calculated in sieverts (Sv).
The ERR of solid organ malignancy, as given by the BEIR VII model, is  s D exp {e*} (a/60), where s, , and 
are data-derived parameters, e is age at exposure, and e*  (e-30)/10 for e < 30 and zero for e > 30, a is attained age,
andD is dose in sieverts. Dose-weighted ERRs were calculated to allow a comparison of malignancy risk when using a CT
at all time points (model 1: 0, 1, 6, 12, and 18 months, 2, 3, and 4 years, and yearly thereafter) vs replacing the CT scan
with two other models (model 2: CT once in 3 years) and (model 3: CT once in 5 years). The risk was stratified by age
groups, sex, and use of two different radiation doses (15 or 31mSv) per CT scan. Statistical analysis used the paired t test.
Results: There were significant differences between the ERR of solid organ malignancy in those patients who would
undergo surveillance CTs at all time points vs those whose surveillance consisted of alternative modalities at some time
points (P < .0001). The cumulative ERR of cancer from radiation was higher in those exposed to contrast-enhanced CT
scans, younger people, with highest in the group aged 50 to 55 years (ERR, 0.43), and lowest in patients aged>80 years
(ERR, 0.10).
Conclusions: Patients undergoing routine CT scans for postoperative surveillance after EVAR are at risk for acquiring new
solid organ malignancy due to radiation exposure. The risk is higher in young patients, women, and those exposed to
multiple contrast-enhanced CT scans. Our analysis questions the need for routine surveillance CT scans after EVAR in the























uComputed tomography (CT) is an integral part of
postoperative surveillance imaging in patients who have
undergone an endovascular abdominal aortic aneurysm
repair (EVAR). Individuals undergoing EVAR require
monitoring for endoleak and subsequent changes in the
aneurysm sac that may lead to aneurysm rupture. There is a
growing concern regarding the long-term effects of radia-
tion exposure in patients undergoing medical imaging.
Cancer, development of cataracts, and impaired fertility are
among some of the effects of prolonged radiation expo-
sure.1 Human beings are exposed to various sources of
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http://dx.doi.org/10.1016/j.jvs.2012.02.061adiation, including natural background sources as well as
hose from nonbackground radiation, such as medical ap-
lications, which account for 18% of current sources of
adiation exposure.2 The use of CT imaging has doubled
very 2 years since the early 1980s to nearly 70million scans
n 2007.3 It is estimated that at least 2% of all cancers are
ue to CT scan radiation exposure. One abdominal CT
can is equivalent to the radiation exposure one would
xperience from natural background sources during a
-year period; hence, there is an ever-increasing need to
ddress the indiscriminate use of CT scans.4
The Society for Vascular Surgery (SVS) has published
uidelines for postoperative surveillance after EVAR.5 Pro-
ocols for EVAR surveillance initially were based on the
.S. Food and Drug Administration-sponsored pivotal
rials that consisted of CT scans at 1, 6, and 12months after
he initial repair and then yearly thereafter. Hence, the SVS
ecommends contrast-enhanced CT imaging at 1 and 12
onths during the first year after EVAR. If an endoleak or
ther abnormality is identified at the 1-month CT surveil-
ance, then a CT scan at 6 months is suggested. If an
ndoleak or aneurysm expansion is not detected, duplex
ltrasound (DUS) imaging may be a reasonable alternative
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October 2012930 Motaganahalli et alDUS imaging requires a skilled technician and an ac-
credited noninvasive vascular laboratory. The utility of
DUS is limited in morbidly obese patients and in those with
a large ventral hernia. The SVS guidelines give DUS a
“weak” level of recommendation with a “low” quality of
evidence for using DUS as an alternative to CT scans after
the first year despite absence of endoleak or aneurysm
expansion. Meta-analysis studies suggest a high specificity
of 91% with low sensitivity of 69% for DUS in detecting
type 2 endoleaks.9 Increased sensitivity of 97.5% is reported
for contrast-enhanced DUS.10 Hence, evaluations of other
imaging methods are needed while recognizing the long-
term implications of subjecting a patient to inadvertent CT
assessments.
The Biological Effects of Radiation model (BEIR VII),
suggested by the National Institute of Science andNational
Research Council Committee, can be used to assess health
risks from exposure to low levels of low-linear energy
transfer (LET) ionizing radiation such as x-rays and gamma
rays. The BEIR VII addresses the late effects of low-level
low-LET radiation, such as cancer, which can occur many
years after low-dose exposures.11
In this study, we report the estimated risk of radiation
associated solid organ malignancy secondary to CT scans in
patients undergoing EVAR.We compare the excess relative
risk (ERR) in those undergoing routine CT scan surveil-
lance vs those with more limited radiation exposure.
METHODS
Models for estimating risk. The study estimates the
risk of radiation exposure-associated solid organ malig-
nancy secondary to CT scans for postoperative surveillance
in patients who had EVAR. Although a number of models
are available for estimating the risk of cancer in patients
exposed to low-dose radiation, the BEIR VII method is a
dominant model used to estimate this risk. The model was
developed from the life-span study cohort of survivors of
the Hiroshima and Nagasaki atomic bomb explosion. This
cohort included a large number of men and women of all
age groups. Survivors experienced a higher-than-normal
risk of malignancy several years after the initial exposure.
The BEIR VII model allows for estimating a quantitative
risk of cancer from ionizing radiation and is unique because
it is a linear and nonthreshold model that predicts that the
risk of cancer is directly proportional to the dose received
and is additive. The model does not respect a minimum or
safe dose of low radiation. We used the BEIR VII model11
to estimate the ERR of solid organ malignancy by the
Table I. The Biological Effects of Ionizin
the excess relative risk of cancer
BEIR VII model for excess relative risk of canc
s, , and  are data-derived parameters, e is a
for e  30 a is attained age in years, D  doseequation as shown in Table I. tWe analyzed the ERR that a patient would develop a
olid organ malignancy by using the BEIR VII model to
ssess three protocols for surveillance of patients undergo-
ng EVAR. This included the ERR for patients having
outine CT scan surveillance, which was often used in the
arlier days of EVAR. In model 1, surveillance CT imaging
as obtained before repair and at 0, 1, 6, 12, 18, 24, 36,
nd 48 months, and yearly thereafter. Model 2 estimated
he risk in patients having fewer CT scans, at 0, 1, and 12
onths, and then once at 3 years after EVAR, with nonra-
iation modalities used for surveillance at other time peri-
ds. Model 3 uses a much-reduced CT imaging paradigm,
ith scans at 0, 1, 12, and 60 months and then once every
years.
The ERR was also determined for age groups at inter-
als of 5 years starting at age 50. The ERR for developing
olid organ cancer was calculated according to the expected
umber of CT studies required; hence, radiation exposure
pread over the life expectancy of the groups. The preop-
rative CT scan was included in the analysis because this is
n additional radiation dose exposure and is additive to the
ong-term risk of acquiring a cancer. Further, our analysis
lso estimated relative risk reduction (RRR) of a patient
eveloping a solid organmalignancy by comparingmodel 1
ith models 2 and 3.
The ERR considers how the normal risk changes with
ge and that incurred by any organism due to excess radi-
tion exposure other than background radiation. The BEIR
II model gives ERR as a multiplier above that already
ncurred by background radiation. For example, if the
ormal risk of developing a given type of cancer between
ge 50 and 55 years is 0.001, and radiation exposure leads
o an ERR of 2, then the patient’s ERR is 2  0.001 or
.002. Thus, instead of having a normal risk of 0.001 for
ancer in the age interval 50 to 55 years, the risk is increased
o 0.002 because of the radiation exposure.
The biologic effects of radiation are described using
equivalent dose,” which is measured in the International
ystem (SI) unit of sievert (Sv). Conventionally, it is mea-
ured in REM (roentgen equivalent in man) with 1 Sv 
00 REM. The “equivalent dose” sievert is also a product
f absorbed dose (RAD or Gy) and weighting factors
WR). The type of radiation used in medical exposures has
WR 1; and hence, sievertRAD. The BEIRVIImodel
ses radiation dose exposure in sieverts.
An individual is exposed to a low dose of radiation with
very CT scan. Although the amount of radiation exposure
ay differ between institutions for an identical study, for
diation (BEIR VII) model for estimating
s D exp ( e*) (a/60)
exposure, e*  (e – 30)/10 for e  30 and 0
vertsg Ra
er 
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Volume 56, Number 4 Motaganahalli et al 931effective dose of 31mSv as the exposure dose for a contrast-
enhanced CT scan and 15 mSv for a noncontrast CT scan.
The mean age of a patient undergoing EVAR in United
States is 72 years, and the current projected life expectancy
at birth, as suggested by U.S. Census Bureau,12 is 80.9
years for a white woman with an average age of 78.6 years.
This study analyzed the ERR up to age 80 years. Assuming
that a patient will be compliant with postoperative follow-
up, we calculated the number of CT scans that an individual
will receive in his or her life span solely for the purpose of
surveillance after EVAR using the models mentioned
above.
Because one is exposed to a lesser dose of radiation with
noncontrast CT scan (15 mSv) rather than a contrast-
enhanced CT scan (31 mSv), our analysis also included
estimating the ERR with these two doses of radiation
exposure for all three models. In addition, the ERR was
computed based on sex because the BEIRVIImodel allows
for such a risk estimation. Using the ERR, we then calcu-
lated the probability of new cancers for all three models of
surveillance.
Statistical analysis. Statistical analysis was performed
using the paired t tests, with each patient having a cumula-
tive ERR for solid organ malignancy secondary to CT
surveillance studies as mandated by the three models. Dif-
ferences in the cumulative ERR were compared between
models 1 and 2 as well between models 1 and 3. The
difference was considered significant at a value of P  .05.
Similar comparisons were made for various age groups and
at two different radiation dose exposures for the three
models. Bonferroni corrections were used to prevent in-
flated type I errors.
RESULTS
The ERRs for radiation-associated solid organ cancer
for patients exposed to noncontrast-enhanced CT scans for
the three models are summarized in Table II. As an exam-
ple, the ERR suggests that patients in the age group of 50
to 55 years have a higher ERR (0.21) than those aged80
Table II. Age-stratified excess relative risk (ERR) and rela





ERR 0.21 0.17 0.14
Model 2b
ERR 0.08 0.07 0.05
RRR 2.63 2.43 2.8
Model 3c
ERR 0.06 0.05 0.04
RRR 3.5 3.4 3.5
aSurveillance computed tomography imaging obtained before endovascular
bSurveillance computed tomography scans at 0, 1, and 12 months, once at
cSurveillance computed tomography scans at 0, 1, 12, and 60 months, and(0.08) because of the ever-increasing number of radiation txposures over time in model 1. Women tend to have a
igher ERR, and are therefore at an increased lifetime risk
or a new malignancy. Women aged 50 to 55 years have a
igher ERR (0.26) than men (0.15) of a similar age.
Fig 1 depicts the estimated ERR for various age
roups and both sexes using a 15-mSv dose of radiation
or CT scans for all three models. As assessed by paired
-tests, young patients (group aged 50-55 years) have a
tatistically significant RRR for acquiring new cancers
hen comparing models 1 and 2 (RRR, 2.63; P 
0001) and models 1 and 3 (RRR, 3.50; P  .0001). As
eported in Table II, patients of all age groups have an
RR when comparing model 1 with model 2 as well as
odel 1 with model 3, suggesting a reduced risk of
ancers with reduced radiation exposure. Similar trends
ere observed in both men and women (Table III, Fig
). There were no statistically significant differences in
RR or RRR between models 2 and 3.
Similarly, we estimated the ERR for patients having
ontrast-enhanced CT studies that were calculated using
1-mSv radiation exposure (Fig 3). Patients in the group
ged 50 to 55 years have an estimated ERR of 0.43,
hereas patients aged 80 years have an ERR of 0.10,
uggesting that young patients have a significantly in-
reased risk of acquiring a new solid organ malignancy
ased solely on the additional radiation exposure ob-
ained for surveillance imaging. The estimated ERR and
RR for various age groups, both sexes, and models are
ummarized in Table IV. Statistical testing suggests a
ignificant difference of the cumulative ERR when com-
aring models 1 and 2 (P  .0001) and models 1 and 3
P  .0001). The risk of a new solid cancer for patients
n the model 1 surveillance protocol is statistically more
possibility than those following a less intense CT
rotocol (models 2 and 3).
At a continued radiation exposure dose of 31-mSv,
omen in the age group of 50 to 55 years have a higher
RR of 0.54 compared with 0.31 for men of similar age.
hen compared with model 1 patients, those following
risk reduction (RRR) in all models in men and women
adiation dose of 15 mSV
n years
P70 70-75 75-80 80
0.08 0.05 0.08
0.03 0.02 0.07
2.67 2.5 1.14 .0001
0.02 0.02 0.07
4 2.5 1.14 .0001
, at 0, 1, 6, 12, 18, 24, 36, and 48 months, and yearly thereafter.



















JOURNAL OF VASCULAR SURGERY
October 2012932 Motaganahalli et alsignificant RRR for all age groups, which are as reported
in Table IV. As seen with the 15-mSv radiation dose, a
subanalysis of the male and female patients at the 31-mSv
radiation exposure dose for all three models also suggests
a statistically significant reduced ERR (Fig 4) and RRR
when model 1 is compared with the surveillance proto-
cols in models 2 and 3. Details of the results are as
Fig 1. Dose-weighted cumulative excess relative risk (E
15-mSv radiation dose according to the Biological Effec
Table III. Age-stratified and sex-stratified excess relative r






Males 0.15 0.13 0.1
Females 0.26 0.22 0.17
Model 2b
ERR
Males 0.06 0.05 0.04
Females 0.1 0.08 0.07
RRR
Males 2.5 2.6 2.5
Females 2.6 2.75 2.43
Model 3c
ERR
Males 0.04 0.03 0.03
Females 0.07 0.06 0.05
RRR
Males 3.75 4.33 3.33
Females 3.71 3.67 3.4
aSurveillance computed tomography imaging obtained before endovascular
bSurveillance computed tomography scans at 0, 1, and 12 months, once at
cSurveillance computed tomography scans at 0, 1, 12, and 60 months, andreported in Table V. tIn translating the ERR derived from the model, a
2-year-old man or woman undergoing EVAR will be
xposed to an excess risk of 1.17 times greater than the
onexposed group for model 1, 1.07 for model 2, and 1.05
or model 3 for new solid organ cancers. From BEIR VII
odel analysis, individuals who were not exposed to any
dditional radiation carry a risk of 0.05 for new cancers due
of solid organ cancer for both sexes calculated using a
onizing Radiation (BEIR VII) model.
RR) and relative risk reduction (RRR) for all models
-mSv radiation dose exposure
in years
P-70 70-75 75-80 80
08 0.06 0.04 0.06
13 0.1 0.06 0.1
03 0.02 0.02 0.05 .0001
05 0.04 0.03 0.09 .0001
67 3 2 1.2
6 2.5 2 1.11
02 0.02 0.01 0.05 .0001
04 0.03 0.02 0.08 .0001
3 4 1.2
25 3.33 3 1.25
, at 0, 1, 6, 12, 18, 24, 36, and 48 months, and yearly thereafter.
s, and using nonradiation surveillance at other assessments.
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There has been an exponential threefold increase in
the number of CT scans performed in the United States
since the early 1980. Approximately 70 million CT scans
are performed annually.13 It is not a routine practice to
discuss with patients the long-term risks associated with
diagnostic radiation exposure, and 92% to 95% of pa-
tients are not informed of the radiation-associated risk of
cancer.14 It is imperative that patients be informed of
potential risks, particularly in complex procedures and in
medical conditions where repeated radiologic proce-
dures are required,15,16 such as serial surveillance stud-
ies.
Most radiation sources have a mixture of high-LET and
low-LET radiation. Compared with high-LET radiation,
low-LET radiation deposits less energy in the cell along the
Fig 2. Dose-weighted cumulative excess relative risk (
15-mSv radiation dose according to the Biological Effecradiation path and is considered less destructive per radia- mion track. The BEIR VII report defines low doses as those
n the range of near 0 up to100mSv (0.1 Sv) of low-LET
adiation. People in the United States are exposed to an
verage annual background radiation level of about 3 mSv,
nd exposure from one whole-body CT scan may equal or
urpass this exposure.
The available biologic and biophysical data from the
adiation Effect Research Foundation (RERF) in Japan,
hich has studied the Hiroshima and Nagasaki atomic
omb survivors over time, supports a “linear-no-threshold”
isk model. In other words, the risk of cancer pro-
eeds in a linear fashion at lower doses, without a thresh-
ld, so that the smallest dose has the potential to cause a
mall increase in the cancer risk. The BEIR VII report
oncludes that the current scientific evidence is consis-
ent with the hypothesis that at the low doses of 100
) of solid organ cancer based on sex calculated using
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October 2012934 Motaganahalli et alexposure to ionizing radiation and the development of
solid cancers in humans. It is unlikely that there is a
threshold below which cancers are not induced, but at
low doses the number of radiation-induced cancers will
be small.11,17
The risks that a person will acquire a solid organ
cancer are worrisome when one considers the overall
prevalence of CT imaging preformed in the United
States. Radiation exposure from each CT scan is equiva-
lent to 30 to 442 chest radiographs, depending on the
technique used. One CT scan may cause as much expo-
sure as a person would receive during a 3-year period
from natural background radiation. A study by Ber-
rington de González et al18 estimates that up to 29,000
excess cancers may result in the next 20 to 30 years as a
Fig 3. Dose-weighted cumulative excess relative risk (E
31-mSv radiation dose according to the Biological Effec
Table IV. Age-stratified excess relative risk (ERR) and rel
contrast-enhanced computed tomography scans at 31-mSv
Model
Age gr
50-55 55-60 60-65 
Model 1a
ERR 0.43 0.36 0.28
Model 2b
ERR 0.17 0.14 0.11
RRR 2.53 2.57 2.55
Model 3c
ERR 0.12 0.10 0.08
RRR 3.58 3.60 3.50
aSurveillance computed tomography imaging obtained before endovascular
bSurveillance computed tomography scans at 0, 1, and 12 months, once at
cSurveillance computed tomography scans at 0, 1, 12, and 60 months, anddirect result of the 72 million CT scans performed in y007. Assuming 50% mortality from these malignancies,
he authors suggest that 15,000 deaths annually may be
direct result.18
It is also increasingly recognized that radiation expo-
ure early in life is most detrimental. Radiation not only
nitiates but also promotes carcinogenesis. The radiation-
ssociated cancer risk may be twice that originally projected
nd has implications regarding medical imaging.19 A simi-
ar conclusion can be made from the data presented in this
tudy because the ERR of cancer in younger patients is
uch higher than that noted in the elderly. Because some
atients undergoing EVAR need such stringent follow-up,
his increased risk of a new malignancy must be taken into
ccount when considering offering an EVAR to a patient
ith a long life expectancy, for example, those aged 60
of solid organ cancer for both sexes calculated using a
onizing Radiation (BEIR VII) model.
risk reduction (RRR) for all models for both sexes using
ation dose exposure
n years
P0 70-75 75-80 80
0.16 0.10 0.10
0.07 0.05 0.08
2.29 2.0 1.25a .0001
0.05 0.04 0.08 .0001
3.20 2.50 1.25
, at 0, 1, 6, 12, 18, 24, 36, and 48 months, and yearly thereafter.
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Volume 56, Number 4 Motaganahalli et al 935Brenner20 suggests that CT scans should operate under
the ALARA principle (As Low as Reasonably Achievable) in
use and radiation dose. This includes not only eliminating
unnecessary CT scans that will not change treatment deci-
sions but also reducing the dose of radiation exposure by
substituting imaging that does not use radiation, when
possible.20 The same principles should be applied when
monitoring patients after EVAR with CT surveillance im-
aging. Applying the ALARA principle to patients undergo-
ing EVAR will involve more liberal use of DUS for the
monitoring purposes; use of CT scans only in case of
aneurysm sac expansion, demonstration of endoleaks, or
difficulties with anatomy; or to investigate a change in a
patient’s symptoms.21
Radiation doses from commonly performed diagnostic
CT examinations are higher and more variable than gener-
ally quoted, highlighting the need for greater standardiza-
tion across institutions.3,13 There are also concerns for dose
optimization, because the amount of radiation dose ab-
sorbed by the patient may differ among the scanners,
although they are the same type and model.22 Current
methods for estimating and reporting radiation dose from
Fig 4. Dose-weighted cumulative excess relative risk (
31-mSv radiation dose according to the Biological EffecCT examinations are largely patient-generic and do not Eeflect patient body size, and hence, dose variation from
atient to patient. A large library of patient-specific com-
uter models, encompassing patients of all ages and weight
ercentiles, can be constructed from which dose and risk
an be estimated for any patient before or after a CT
xamination.23
Patients undergoing EVARwill have delayed endoleaks
nd need for secondary interventions. Reinterventions after
VAR are required even years after the initial procedure.
owever, it does appear that this is a finite number of
atients, so intensive surveillance is likely needed in only
his cohort of patients. TheEuropeanCollaborators on Stent-
raft Techniques forAAAandThoracicAortic Aneurysm and
issection Repair (EUROSTAR) collaborators noted a de-
ayed aneurysm rupture risk of 1% in their series of EVAR
atients at 4 years, despite an 8-mm increase in aneurysm
iameter but without endoleaks.24 We need to define the
t-risk patients more carefully to eliminate unnecessary and
otentially harmful imaging. Although the need for a CT scan
or follow-up cannot be completely eliminated, efforts should
e made to decrease the frequency.
When neither the 1-month nor the 1-year CT scan after
) of solid organ cancer based on sex calculated using
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October 2012936 Motaganahalli et alin sac morphology, or stent migration, then it might be
appropriate to consider using modalities other than a CT to
monitor the patient. The analysis from our study shows that
simply decreasing the frequency and radiation dose expo-
sure will dramatically decrease the risk of a new solid cancer
over the life of the patient.
The limitations of this analysis include the assumptions
that were required to allow the calculations to be made to a
projected life span of an individual, which may or may not
reflect that of a patient who requires an EVAR. Further-
more, the modeling assumes that a patient will be fully
compliant with the postoperative surveillance protocol.
Despite these limitations, the study provides an awareness
of the potential risk of cancer that our EVAR surveillance
protocols might subject our patients to over time, especially
if young female patients.
CONCLUSIONS
Patients who undergo routine CT scans for postopera-
tive surveillance after EVAR are at additional risk for acquir-
ing new solid organ malignancy due to the inherent radia-
tion exposure. The risk is more pronounced in younger
patients, women, and those exposed to contrast-enhanced
CT scans. Our analysis alerts the surgeon to one more risk
the EVAR patient will face if we are indiscriminate in the
use of surveillance CT imaging. In some cases, it might be
wise to consider alternative imaging modalities, at least for
some of the surveillance assessments.
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